CDC blocks COVID vaccine effectiveness report over methodological concerns

The Centers for Disease Control and Prevention will not publish a COVID-19 vaccine effectiveness report in its flagship journal after reviewers raised concerns about how the study measured protection. The decision matters well beyond the agency’s walls because the report was meant for the Morbidity and Mortality Weekly Report, the CDC’s main channel for timely public-health guidance.

The U.S. Department of Health and Human Services confirmed the rejection and said the manuscript was not accepted because of methodological concerns about the way vaccine effectiveness was estimated. HHS spokesperson Andrew Nixon said the scientific review process runs through multiple levels to ensure papers meet publication standards. That explanation puts the dispute squarely on process, not on the underlying question of whether vaccines worked during the winter.

The report reportedly found that COVID vaccines cut emergency department visits and hospitalizations among healthy adults by about half during the winter. Its disappearance from MMWR could slow the spread of fresh evidence to physicians, nurses, epidemiologists, researchers, educators and laboratorians, the core audience that relies on the journal for the CDC’s most direct scientific communications. The CDC describes MMWR as its primary vehicle for scientific publication and for timely, reliable public-health recommendations.

The episode is unfolding against a broader fight over vaccine policy under Health Secretary Robert F. Kennedy Jr., whose leadership has already reshaped federal immunization politics. On March 16, 2026, U.S. District Judge Brian E. Murphy issued a preliminary injunction that stayed Kennedy’s appointments to the Advisory Committee on Immunization Practices, stayed votes taken by the panel, and blocked the heavily revised vaccine schedule. That legal fight underscored how quickly public-health decisions have become entangled with courtroom battles and accusations of political interference.

The CDC’s current COVID-19 guidance still recommends vaccination for adults 65 and older through individual-based decision-making, and says people can self-attest to factors that raise their risk for severe COVID-19 and still receive vaccination. The guidance also lays out schedules for people who are moderately or severely immunocompromised.

For doctors and state health departments, the practical concern is not just this one paper. It is whether a methodological objection was handled as a normal scientific review issue or as part of a broader effort to slow the release of findings that could shape vaccine policy, especially as respiratory-virus season approaches. In public health, the distinction between scientific caution and political pressure is not academic. It is the difference between evidence that builds trust and silence that erodes it.